1
|
Mrkvicová A, Peterová E, Nemec I, Křikavová R, Muthná D, Havelek R, Kazimírová P, Řezáčová M, Štarha P. Rh(III) and Ru(II) complexes with phosphanyl-alkylamines: inhibition of DNA synthesis induced by anticancer Rh complex. Future Med Chem 2023; 15:1583-1602. [PMID: 37750220 DOI: 10.4155/fmc-2023-0170] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/27/2023] Open
Abstract
Aim: This investigation was designed to synthesize half-sandwich Rh(III) and Ru(II) complexes and study their antiproliferative activity in human cancer cell lines. Materials & methods: Nine compounds were prepared and tested by various assays for their anticancer activity and mechanism of action. Results: Hit Rh(III) complex 6 showed low-micromolar potency in cisplatin-sensitive (A2780) and -resistant (A2780cis) ovarian carcinoma cell lines, promising selectivity toward these cancer cells over normal lung fibroblasts and an unprecedented mechanism of action in the treated cells. DNA synthesis was decreased and CDKN1A expression was upregulated, but p21 expression was not induced. Conclusion: Rh complex 6 showed high antiproliferative activity, which is induced through a p21-independent mechanism of action.
Collapse
Affiliation(s)
- Alena Mrkvicová
- Department of Medical Biochemistry, Charles University, Šimkova 870, 500 03, Hradec Králové, Czech Republic
| | - Eva Peterová
- Department of Medical Biochemistry, Charles University, Šimkova 870, 500 03, Hradec Králové, Czech Republic
| | - Ivan Nemec
- Department of Inorganic Chemistry, Palacký University Olomouc, 17. listopadu 12, 771 46, Olomouc, Czech Republic
| | - Radka Křikavová
- Department of Inorganic Chemistry, Palacký University Olomouc, 17. listopadu 12, 771 46, Olomouc, Czech Republic
| | - Darina Muthná
- Department of Medical Biochemistry, Charles University, Šimkova 870, 500 03, Hradec Králové, Czech Republic
| | - Radim Havelek
- Department of Medical Biochemistry, Charles University, Šimkova 870, 500 03, Hradec Králové, Czech Republic
| | - Petra Kazimírová
- Department of Medical Biochemistry, Charles University, Šimkova 870, 500 03, Hradec Králové, Czech Republic
| | - Martina Řezáčová
- Department of Medical Biochemistry, Charles University, Šimkova 870, 500 03, Hradec Králové, Czech Republic
| | - Pavel Štarha
- Department of Inorganic Chemistry, Palacký University Olomouc, 17. listopadu 12, 771 46, Olomouc, Czech Republic
| |
Collapse
|
2
|
Ravi A, Pathigoolla A, Balan H, Gupta R, Raj G, Varghese R, Sureshan KM. Adamantoid Scaffolds for Multiple Cargo Loading and Cellular Delivery as β-Cyclodextrin Inclusion Complexes. Angew Chem Int Ed Engl 2023; 62:e202307324. [PMID: 37384430 DOI: 10.1002/anie.202307324] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2023] [Revised: 06/24/2023] [Accepted: 06/29/2023] [Indexed: 07/01/2023]
Abstract
There is huge demand for developing guests that bind β-CD and can conjugate multiple cargos for cellular delivery. We synthesized trioxaadamantane derivatives, which can conjugate up to three cargos per guest. 1 H NMR titration and isothermal titration calorimetry revealed these guests form 1 : 1 inclusion complexes with β-CD with association constants in the order of 103 M-1 . Co-crystallization of β-CD with guests yielded crystals of their 1 : 1 inclusion complexes as determined by single-crystal X-ray diffraction. In all cases, trioxaadamantane core is buried within the hydrophobic cavity of β-CD and three hydroxyl groups are exposed outside. We established biocompatibility using representative candidate G4 and its inclusion complex with β-CD (β-CD⊂G4), by MTT assay using HeLa cells. We incubated HeLa cells with rhodamine-conjugated G4 and established cellular cargo delivery using confocal laser scanning microscopy (CLSM) and fluorescence-activated cell sorting (FACS) analysis. For functional assay, we incubated HeLa cells with β-CD-inclusion complexes of G4-derived prodrugs G6 and G7, containing one and three units of the antitumor drug (S)-(+)-camptothecin, respectively. Cells incubated with β-CD⊂G7 displayed the highest internalization and uniform distribution of camptothecin. β-CD⊂G7 showed higher cytotoxicity than G7, camptothecin, G6 and β-CD⊂G6, affirming the efficiency of adamantoid derivatives in high-density loading and cargo delivery.
Collapse
Affiliation(s)
- Arthi Ravi
- School of Chemistry, Indian Institute of Science Education and Research Thiruvananthapuram, Thiruvananthapuram, Vithura, 695551, India
| | - Atchutarao Pathigoolla
- School of Chemistry, Indian Institute of Science Education and Research Thiruvananthapuram, Thiruvananthapuram, Vithura, 695551, India
| | - Haripriya Balan
- School of Chemistry, Indian Institute of Science Education and Research Thiruvananthapuram, Thiruvananthapuram, Vithura, 695551, India
| | - Ria Gupta
- School of Chemistry, Indian Institute of Science Education and Research Thiruvananthapuram, Thiruvananthapuram, Vithura, 695551, India
| | - Gowtham Raj
- School of Chemistry, Indian Institute of Science Education and Research Thiruvananthapuram, Thiruvananthapuram, Vithura, 695551, India
| | - Reji Varghese
- School of Chemistry, Indian Institute of Science Education and Research Thiruvananthapuram, Thiruvananthapuram, Vithura, 695551, India
| | - Kana M Sureshan
- School of Chemistry, Indian Institute of Science Education and Research Thiruvananthapuram, Thiruvananthapuram, Vithura, 695551, India
| |
Collapse
|
3
|
Lu Y, Sheng X, Liu C, Liang Z, Wang X, Liu L, Wen Z, Yang Z, Du Q, Liu W. SERD-NHC-Au(I) complexes for dual targeting ER and TrxR to induce ICD in breast cancer. Pharmacol Res 2023; 190:106731. [PMID: 36933755 DOI: 10.1016/j.phrs.2023.106731] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/02/2022] [Revised: 03/13/2023] [Accepted: 03/14/2023] [Indexed: 03/19/2023]
Abstract
The development of selective estrogen receptor degraders (SERDs) has brought new ideas for the clinical treatment of ER-positive advanced breast cancer. The successful application of combinational therapy inspired the exploration of other targets to prevent breast cancer progression. Thioredoxin reductase (TrxR) is an important enzyme that can regulate redox balance in cells and it was considered as a potential target for anticancer treatment. In this study, we firstly combine a clinical SERD candidate--G1T48 (NCT03455270), with a TrxR inhibitor--N-heterocyclic carbene gold(I) [NHC-Au(I)] to form dual targeting complexes that can regulate both signaling pathways. The most efficacious complex 23 exhibited significant antiproliferative profile through degrading ER and inhibiting TrxR activity. Interestingly, it can induce immunogenic cell death (ICD) caused by ROS. This is the first evidence to elucidate the role of ER/TrxR-ROS-ICD axis in ER positive breast cancer and this research may inspire new drug development with novel mechanisms. The in vivo xenograft study demonstrated that complex 23 had excellent antiproliferative activity toward MCF-7 cells in mice model.
Collapse
Affiliation(s)
- Yunlong Lu
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, PR China
| | - Xinyu Sheng
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, PR China
| | - Chao Liu
- Department of Pharmacy, Nanjing First Hospital, Nanjing Medical University, Nanjing 210029, PR China; School of Basic Medicine & Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, PR China
| | - Zhenlin Liang
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, PR China
| | - Xin Wang
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, PR China
| | - Lijuan Liu
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, PR China
| | - Zhenfan Wen
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, PR China
| | - Zhibin Yang
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, PR China; Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical R&D, Dali University, Dali 671000, PR China
| | - Qianming Du
- General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, PR China; School of Basic Medicine & Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, PR China.
| | - Wukun Liu
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, PR China; State key Laboratory of Coordination Chemistry, Nanjing University, Nanjing 210023, PR China.
| |
Collapse
|
4
|
Lu Y, Ma X, Chang X, Liang Z, Lv L, Shan M, Lu Q, Wen Z, Gust R, Liu W. Recent development of gold(I) and gold(III) complexes as therapeutic agents for cancer diseases. Chem Soc Rev 2022; 51:5518-5556. [PMID: 35699475 DOI: 10.1039/d1cs00933h] [Citation(s) in RCA: 54] [Impact Index Per Article: 27.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
Metal complexes have demonstrated significant antitumor activities and platinum complexes are well established in the clinical application of cancer chemotherapy. However, the platinum-based treatment of different types of cancers is massively hampered by severe side effects and resistance development. Consequently, the development of novel metal-based drugs with different mechanism of action and pharmaceutical profile attracts modern medicinal chemists to design and synthesize novel metal-based agents. Among non-platinum anticancer drugs, gold complexes have gained considerable attention due to their significant antiproliferative potency and efficacy. In most situations, the gold complexes exhibit anticancer activities by targeting thioredoxin reductase (TrxR) or other thiol-rich proteins and enzymes and trigger cell death via reactive oxygen species (ROS). Interestingly, gold complexes were recently reported to elicit biochemical hallmarks of immunogenic cell death (ICD) as an ICD inducer. In this review, the recent progress of gold(I) and gold(III) complexes is comprehensively summarized, and their activities and mechanism of action are documented.
Collapse
Affiliation(s)
- Yunlong Lu
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
| | - Xiaoyan Ma
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
| | - Xingyu Chang
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
| | - Zhenlin Liang
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
| | - Lin Lv
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
| | - Min Shan
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
| | - Qiuyue Lu
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
| | - Zhenfan Wen
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
| | - Ronald Gust
- Institute of Pharmacy/Pharmaceutical Chemistry, University of Innsbruck, Center for Chemistry and Biomedicine, Innsbruck, Austria.
| | - Wukun Liu
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China. .,State key Laboratory of Coordination Chemistry, Nanjing University, Nanjing, 210023, China
| |
Collapse
|
5
|
Rousselle B, Massot A, Privat M, Dondaine L, Trommenschlager A, Bouyer F, Bayardon J, Ghiringhelli F, Bettaieb A, Goze C, Paul C, Malacea-Kabbara R, Bodio E. Conception and evaluation of fluorescent phosphine-gold complexes: from synthesis to in vivo investigations. ChemMedChem 2022; 17:e202100773. [PMID: 35254001 DOI: 10.1002/cmdc.202100773] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2021] [Revised: 03/02/2022] [Indexed: 11/11/2022]
Abstract
A phosphine gold(I) and phosphine-phosphonium gold(I) complexes bearing a fluorescent coumarin moiety were synthesized and characterized. Both complexes displayed interesting photophysical properties: good molar absorption coefficient, good quantum yield of fluorescence, and ability to be tracked in vitro thanks to two-photon imaging. Their in vitro and in vivo biological properties were evaluated onto cancer cell lines both human and murine and into CT26 tumor-bearing BALB/c mice. They displayed moderate to strong antiproliferative properties and the phosphine-phosphonium gold(I) complex induced significant in vivo anti-cancer effect.
Collapse
Affiliation(s)
- Benjamin Rousselle
- Université Bourgogne Franche-Comté: Universite Bourgogne Franche-Comte, ICMUB, FRANCE
| | - Aurélie Massot
- EPHE PSL: Ecole Pratique des Hautes Etudes, LIIC, FRANCE
| | - Malorie Privat
- Université Bourgogne Franche-Comté: Universite Bourgogne Franche-Comte, ICMUB and LIIC, FRANCE
| | - Lucile Dondaine
- Université Bourgogne Franche-Comté: Universite Bourgogne Franche-Comte, ICMUB and LIIC, FRANCE
| | | | - Florence Bouyer
- Université Bourgogne Franche-Comté: Universite Bourgogne Franche-Comte, INSERM 1231, FRANCE
| | - Jérôme Bayardon
- Université Bourgogne Franche-Comté: Universite Bourgogne Franche-Comte, ICMUB, FRANCE
| | - François Ghiringhelli
- Université Bourgogne Franche-Comté: Universite Bourgogne Franche-Comte, INSERM UMR 1231, FRANCE
| | - Ali Bettaieb
- EPHE PSL: Ecole Pratique des Hautes Etudes, LIIC, FRANCE
| | - Christine Goze
- Université Bourgogne Franche-Comté: Universite Bourgogne Franche-Comte, ICMUB, FRANCE
| | - Catherine Paul
- EPHE PSL: Ecole Pratique des Hautes Etudes, LIIC, FRANCE
| | | | - Ewen Bodio
- Burgundy University, Institut de Chimie Moleculaire de l'Universite de Bourgogne - UMR CNRS 6302, 9 avenue Alain Savary, BP 47870, 21078, Dijon, FRANCE
| |
Collapse
|
6
|
Abstract
A growing theme in chemistry is the joining of multiple organic molecular building blocks to create functional molecules. Diverse derivatizable structures—here termed “scaffolds” comprised of “hubs”—provide the foundation for systematic covalent organization of a rich variety of building blocks. This review encompasses 30 tri- or tetra-armed molecular hubs (e.g., triazine, lysine, arenes, dyes) that are used directly or in combination to give linear, cyclic, or branched scaffolds. Each scaffold is categorized by graph theory into one of 31 trees to express the molecular connectivity and overall architecture. Rational chemistry with exacting numbers of derivatizable sites is emphasized. The incorporation of water-solubilization motifs, robust or self-immolative linkers, enzymatically cleavable groups and functional appendages affords immense (and often late-stage) diversification of the scaffolds. Altogether, 107 target molecules are reviewed along with 19 syntheses to illustrate the distinctive chemistries for creating and derivatizing scaffolds. The review covers the history of the field up through 2020, briefly touching on statistically derivatized carriers employed in immunology as counterpoints to the rationally assembled and derivatized scaffolds here, although most citations are from the past two decades. The scaffolds are used widely in fields ranging from pure chemistry to artificial photosynthesis and biomedical sciences.
Collapse
|
7
|
Lescure R, Privat M, Pliquett J, Massot A, Baffroy O, Busser B, Bellaye PS, Collin B, Denat F, Bettaïeb A, Sancey L, Paul C, Goze C, Bodio E. Near-infrared emitting fluorescent homobimetallic gold(I) complexes displaying promising in vitro and in vivo therapeutic properties. Eur J Med Chem 2021; 220:113483. [PMID: 33915372 DOI: 10.1016/j.ejmech.2021.113483] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2021] [Revised: 04/07/2021] [Accepted: 04/13/2021] [Indexed: 12/24/2022]
Abstract
Three near-infrared (NIR-I) optical theranostic systems were synthesized, characterized and studied in vitro and in vivo. These original homo-bimetallic gold(I)-based aza-BODIPY complexes proved to be trackable through near-infrared optical imaging in cells and in mice. They display anti-proliferative properties in micromolar range against human and murine cancer cell lines (4T1, MDA-MB-231, CT26, and SW480). Moreover, the injection of the most promising theranostic agent in CT26 tumor-bearing BALB/c mice induced a significant anti-cancer activity.
Collapse
Affiliation(s)
- Robin Lescure
- ICMUB UMR6302, CNRS, Univ. Bourgogne Franche-Comté, F-21000, Dijon, France
| | - Malorie Privat
- ICMUB UMR6302, CNRS, Univ. Bourgogne Franche-Comté, F-21000, Dijon, France; Laboratoire d'Immunologie et Immunothérapie des Cancers (LIIC, EA7269), EPHE, PSL Research, University, F-75000, Paris, France, Université de Bourgogne Franche Comté, F-21000, Dijon, France
| | - Jacques Pliquett
- ICMUB UMR6302, CNRS, Univ. Bourgogne Franche-Comté, F-21000, Dijon, France; Laboratoire d'Immunologie et Immunothérapie des Cancers (LIIC, EA7269), EPHE, PSL Research, University, F-75000, Paris, France, Université de Bourgogne Franche Comté, F-21000, Dijon, France
| | - Aurélie Massot
- Laboratoire d'Immunologie et Immunothérapie des Cancers (LIIC, EA7269), EPHE, PSL Research, University, F-75000, Paris, France, Université de Bourgogne Franche Comté, F-21000, Dijon, France
| | - Océane Baffroy
- ICMUB UMR6302, CNRS, Univ. Bourgogne Franche-Comté, F-21000, Dijon, France
| | - Benoit Busser
- Institute for Advanced Biosciences, Centre de Recherche UGA / INSERM U1209 / CNRS UMR5309, F-38700, La Tronche, France; Grenoble Alpes University Hospital, F-38042, Grenoble, France
| | - Pierre-Simon Bellaye
- Centre Georges François Leclerc, Service de médecine nucléaire, plateforme d'imagerie et de radiothérapie préclinique, 1 rue Professeur Marion, BP77980, 21079, Dijon Cedex, France
| | - Bertrand Collin
- ICMUB UMR6302, CNRS, Univ. Bourgogne Franche-Comté, F-21000, Dijon, France; Centre Georges François Leclerc, Service de médecine nucléaire, plateforme d'imagerie et de radiothérapie préclinique, 1 rue Professeur Marion, BP77980, 21079, Dijon Cedex, France
| | - Franck Denat
- ICMUB UMR6302, CNRS, Univ. Bourgogne Franche-Comté, F-21000, Dijon, France
| | - Ali Bettaïeb
- Laboratoire d'Immunologie et Immunothérapie des Cancers (LIIC, EA7269), EPHE, PSL Research, University, F-75000, Paris, France, Université de Bourgogne Franche Comté, F-21000, Dijon, France
| | - Lucie Sancey
- Institute for Advanced Biosciences, Centre de Recherche UGA / INSERM U1209 / CNRS UMR5309, F-38700, La Tronche, France
| | - Catherine Paul
- Laboratoire d'Immunologie et Immunothérapie des Cancers (LIIC, EA7269), EPHE, PSL Research, University, F-75000, Paris, France, Université de Bourgogne Franche Comté, F-21000, Dijon, France.
| | - Christine Goze
- ICMUB UMR6302, CNRS, Univ. Bourgogne Franche-Comté, F-21000, Dijon, France.
| | - Ewen Bodio
- ICMUB UMR6302, CNRS, Univ. Bourgogne Franche-Comté, F-21000, Dijon, France.
| |
Collapse
|
8
|
Rousselle B, Bouyer F, Bayardon J, Laly M, Ghiringhelli F, Rousselin Y, Bodio E, Malacea-Kabbara R. Development of a novel highly anti-proliferative family of gold complexes: Au(i)-phosphonium-phosphines. Dalton Trans 2021; 50:4880-4889. [PMID: 33877185 DOI: 10.1039/d0dt03708g] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
A family of gold(i)-phosphonium-phosphine complexes was synthesized thanks to an efficient 5-step strategy, which involves a phospha-Fries rearrangement. It enables the facile variation of the phosphonium moiety. All the complexes along with a synthetic intermediate were fully characterized (a crystal structure was obtained for two of them). The antiproliferative properties of the six novel complexes were evaluated on three human cancer cell lines (A549, MDA-MB-231, and SW480) and compared to those of three benchmark anticancer drugs used in clinics (oxaliplatin, 5-fluorouracil, and paclitaxel) and to a phosphonium-free gold(i) complex [Au(PPh3)Br]. All the gold(i) complexes, containing a phosphonium, displayed strong anti-proliferative properties. They were more efficient than oxaliplatin and 5-fluorouracil, and one of the complexes was even more efficient than paclitaxel.
Collapse
Affiliation(s)
- Benjamin Rousselle
- ICMUB UMR6302, CNRS, Univ. Bourgogne Franche-Comté, F-21000 Dijon, France.
| | | | | | | | | | | | | | | |
Collapse
|
9
|
Geri S, Krunclova T, Janouskova O, Panek J, Hruby M, Hernández‐Valdés D, Probst B, Alberto RA, Mamat C, Kubeil M, Stephan H. Light-Activated Carbon Monoxide Prodrugs Based on Bipyridyl Dicarbonyl Ruthenium(II) Complexes. Chemistry 2020; 26:10992-11006. [PMID: 32700815 PMCID: PMC7496190 DOI: 10.1002/chem.202002139] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2020] [Indexed: 12/13/2022]
Abstract
Two photoactivatable dicarbonyl ruthenium(II) complexes based on an amide-functionalised bipyridine scaffold (4-position) equipped with an alkyne functionality or a green-fluorescent BODIPY (boron-dipyrromethene) dye have been prepared and used to investigate their light-induced decarbonylation. UV/Vis, FTIR and 13 C NMR spectroscopies as well as gas chromatography and multivariate curve resolution alternating least-squares analysis (MCR-ALS) were used to elucidate the mechanism of the decarbonylation process. Release of the first CO molecule occurs very quickly, while release of the second CO molecule proceeds more slowly. In vitro studies using two cell lines A431 (human squamous carcinoma) and HEK293 (human embryonic kidney cells) have been carried out in order to characterise the anti-proliferative and anti-apoptotic activities. The BODIPY-labelled compound allows for monitoring the cellular uptake, showing fast internalisation kinetics and accumulation at the endoplasmic reticulum and mitochondria.
Collapse
Affiliation(s)
- Stepan Geri
- Institute of Radiopharmaceutical Cancer ResearchHelmholtz-Zentrum Dresden-RossendorfBautzner Landstrasse 40001328DresdenGermany
| | - Tereza Krunclova
- Department of Biological ModelsInstitute of Macromolecular ChemistryHeyrovsky Square 216206PragueCzech Republic
| | - Olga Janouskova
- Department of Biological ModelsInstitute of Macromolecular ChemistryHeyrovsky Square 216206PragueCzech Republic
| | - Jiri Panek
- Supramolecular Polymer SystemsInstitute of Macromolecular ChemistryHeyrovsky Square 216206PragueCzech Republic
| | - Martin Hruby
- Supramolecular Polymer SystemsInstitute of Macromolecular ChemistryHeyrovsky Square 216206PragueCzech Republic
| | | | - Benjamin Probst
- Department of ChemistryUniversity of ZurichWinterthurerstr. 1908057ZurichSwitzerland
| | - Roger A. Alberto
- Department of ChemistryUniversity of ZurichWinterthurerstr. 1908057ZurichSwitzerland
| | - Constantin Mamat
- Institute of Radiopharmaceutical Cancer ResearchHelmholtz-Zentrum Dresden-RossendorfBautzner Landstrasse 40001328DresdenGermany
| | - Manja Kubeil
- Institute of Radiopharmaceutical Cancer ResearchHelmholtz-Zentrum Dresden-RossendorfBautzner Landstrasse 40001328DresdenGermany
| | - Holger Stephan
- Institute of Radiopharmaceutical Cancer ResearchHelmholtz-Zentrum Dresden-RossendorfBautzner Landstrasse 40001328DresdenGermany
| |
Collapse
|
10
|
Kalot G, Godard A, Busser B, Pliquett J, Broekgaarden M, Motto-Ros V, Wegner KD, Resch-Genger U, Köster U, Denat F, Coll JL, Bodio E, Goze C, Sancey L. Aza-BODIPY: A New Vector for Enhanced Theranostic Boron Neutron Capture Therapy Applications. Cells 2020; 9:cells9091953. [PMID: 32854219 PMCID: PMC7565158 DOI: 10.3390/cells9091953] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2020] [Revised: 08/18/2020] [Accepted: 08/20/2020] [Indexed: 12/16/2022] Open
Abstract
Boron neutron capture therapy (BNCT) is a radiotherapeutic modality based on the nuclear capture of slow neutrons by stable 10B atoms followed by charged particle emission that inducing extensive damage on a very localized level (<10 μm). To be efficient, a sufficient amount of 10B should accumulate in the tumor area while being almost cleared from the normal surroundings. A water-soluble aza-boron-dipyrromethene dyes (BODIPY) fluorophore was reported to strongly accumulate in the tumor area with high and BNCT compatible Tumor/Healthy Tissue ratios. The clinically used 10B-BSH (sodium borocaptate) was coupled to the water-soluble aza-BODIPY platform for enhanced 10B-BSH tumor vectorization. We demonstrated a strong uptake of the compound in tumor cells and determined its biodistribution in mice-bearing tumors. A model of chorioallantoic membrane-bearing glioblastoma xenograft was developed to evidence the BNCT potential of such compound, by subjecting it to slow neutrons. We demonstrated the tumor accumulation of the compound in real-time using optical imaging and ex vivo using elemental imaging based on laser-induced breakdown spectroscopy. The tumor growth was significantly reduced as compared to BNCT with 10B-BSH. Altogether, the fluorescent aza-BODIPY/10B-BSH compound is able to vectorize and image the 10B-BSH in the tumor area, increasing its theranostic potential for efficient approach of BNCT.
Collapse
Affiliation(s)
- Ghadir Kalot
- Institute for Advanced Biosciences, UGA INSERM U1209 CNRS UMR5309, 38700 La Tronche, France; (G.K.); (B.B.); (M.B.); (J.-L.C.)
| | - Amélie Godard
- Institut de Chimie Moléculaire de l’Université de Bourgogne, ICMUB CNRS, UMR 6302, Université Bourgogne Franche-Comté, 21078 Dijon, France; (A.G.); (J.P.); (F.D.)
| | - Benoît Busser
- Institute for Advanced Biosciences, UGA INSERM U1209 CNRS UMR5309, 38700 La Tronche, France; (G.K.); (B.B.); (M.B.); (J.-L.C.)
- Grenoble Alpes University Hospital, 38043 Grenoble, France
| | - Jacques Pliquett
- Institut de Chimie Moléculaire de l’Université de Bourgogne, ICMUB CNRS, UMR 6302, Université Bourgogne Franche-Comté, 21078 Dijon, France; (A.G.); (J.P.); (F.D.)
| | - Mans Broekgaarden
- Institute for Advanced Biosciences, UGA INSERM U1209 CNRS UMR5309, 38700 La Tronche, France; (G.K.); (B.B.); (M.B.); (J.-L.C.)
| | - Vincent Motto-Ros
- Institut Lumière Matière UMR 5306, Université Lyon 1-CNRS, Université de Lyon, 69622 Villeurbanne, France;
| | - Karl David Wegner
- Division Biophotonics, Federal Institute for Materials Research and Testing (BAM), Richard-Willstaetter-Str. 11, 12489 Berlin, Germany; (K.D.W.); (U.R.-G.)
| | - Ute Resch-Genger
- Division Biophotonics, Federal Institute for Materials Research and Testing (BAM), Richard-Willstaetter-Str. 11, 12489 Berlin, Germany; (K.D.W.); (U.R.-G.)
| | - Ulli Köster
- Institut Laue Langevin, 38042 Grenoble, France;
| | - Franck Denat
- Institut de Chimie Moléculaire de l’Université de Bourgogne, ICMUB CNRS, UMR 6302, Université Bourgogne Franche-Comté, 21078 Dijon, France; (A.G.); (J.P.); (F.D.)
| | - Jean-Luc Coll
- Institute for Advanced Biosciences, UGA INSERM U1209 CNRS UMR5309, 38700 La Tronche, France; (G.K.); (B.B.); (M.B.); (J.-L.C.)
| | - Ewen Bodio
- Institut de Chimie Moléculaire de l’Université de Bourgogne, ICMUB CNRS, UMR 6302, Université Bourgogne Franche-Comté, 21078 Dijon, France; (A.G.); (J.P.); (F.D.)
- Correspondence: (E.B.); (C.G.); (L.S.); Tel.: +33-380-396-076 (E.B.); +33-380-399-043 (C.G.); +33-476-549-410 (L.S.)
| | - Christine Goze
- Institut de Chimie Moléculaire de l’Université de Bourgogne, ICMUB CNRS, UMR 6302, Université Bourgogne Franche-Comté, 21078 Dijon, France; (A.G.); (J.P.); (F.D.)
- Correspondence: (E.B.); (C.G.); (L.S.); Tel.: +33-380-396-076 (E.B.); +33-380-399-043 (C.G.); +33-476-549-410 (L.S.)
| | - Lucie Sancey
- Institute for Advanced Biosciences, UGA INSERM U1209 CNRS UMR5309, 38700 La Tronche, France; (G.K.); (B.B.); (M.B.); (J.-L.C.)
- Correspondence: (E.B.); (C.G.); (L.S.); Tel.: +33-380-396-076 (E.B.); +33-380-399-043 (C.G.); +33-476-549-410 (L.S.)
| |
Collapse
|
11
|
Frank F, Alice LM, Mauker P, Alsimaree AA, Waddell PG, Probert MR, Penfold TJ, Knight JG, Hall MJ. Synthesis of 3,5-dichloro-4,4-difluoro-4-bora-3a,4a-diaza-s-indacenes (BODIPYs) via Cu(OTf)2 mediated oxidative nucleophilic substitution of hydrogen by chloride. Tetrahedron 2020. [DOI: 10.1016/j.tet.2020.131113] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
|
12
|
Florès O, Velic D, Mabrouk N, Bettaïeb A, Tomasoni C, Robert J, Paul C, Goze C, Roussakis C, Bodio E. Rapid Synthesis and Antiproliferative Properties of Polyazamacrocycle‐Based Bi‐ and Tetra‐Gold(I) Phosphine Dithiocarbamate Complexes. Chembiochem 2019; 20:2255-2261. [DOI: 10.1002/cbic.201900227] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2019] [Indexed: 12/26/2022]
Affiliation(s)
- Océane Florès
- CNRSUniversité Bourgogne Franche-ComtéICMUB UMR6302 9 avenue Alain Savary 21000 Dijon France
| | - Denis Velic
- Université de NantesUFR Sciences PharmaceutiquesLaboratoire IIciMed EA1155Département de Cancérologie 9 rue Bias 44035 Nantes France
| | - Nesrine Mabrouk
- EPHEPSL Research UniversityLaboratoire d'Immunologie et Immunothérapie des Cancers 60 Rue Mazarine 75006 Paris France
- Université Bourgogne Franche-ComtéLIIC, EA7269 7 Bd Jeanne d'Arc 21000 Dijon France
| | - Ali Bettaïeb
- EPHEPSL Research UniversityLaboratoire d'Immunologie et Immunothérapie des Cancers 60 Rue Mazarine 75006 Paris France
- Université Bourgogne Franche-ComtéLIIC, EA7269 7 Bd Jeanne d'Arc 21000 Dijon France
| | - Christophe Tomasoni
- Université de NantesUFR Sciences PharmaceutiquesLaboratoire IIciMed EA1155Département de Cancérologie 9 rue Bias 44035 Nantes France
| | - Jean‐Michel Robert
- Université de NantesUFR Sciences PharmaceutiquesLaboratoire IIciMed EA1155Département de Cancérologie 9 rue Bias 44035 Nantes France
| | - Catherine Paul
- EPHEPSL Research UniversityLaboratoire d'Immunologie et Immunothérapie des Cancers 60 Rue Mazarine 75006 Paris France
- Université Bourgogne Franche-ComtéLIIC, EA7269 7 Bd Jeanne d'Arc 21000 Dijon France
| | - Christine Goze
- CNRSUniversité Bourgogne Franche-ComtéICMUB UMR6302 9 avenue Alain Savary 21000 Dijon France
| | - Christos Roussakis
- Université de NantesUFR Sciences PharmaceutiquesLaboratoire IIciMed EA1155Département de Cancérologie 9 rue Bias 44035 Nantes France
| | - Ewen Bodio
- CNRSUniversité Bourgogne Franche-ComtéICMUB UMR6302 9 avenue Alain Savary 21000 Dijon France
| |
Collapse
|
13
|
Liu M, Han Y, Yuan W, Guo C, Shi S, Liu X, Chen Y. Fluorescent BF2 complexes of pyridyl-isoindoline-1-ones: synthesis, characterization and their distinct response to mechanical force. Dalton Trans 2019; 48:14626-14631. [DOI: 10.1039/c9dt02852h] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
Abstract
Three boron-pyridyl-isoindoline-1-one based dyes (B1, B2, and B3) with varied side groups were synthesized and their mechanochromic fluorescence properties were studied.
Collapse
Affiliation(s)
- Meifang Liu
- College of Chemistry-Chemical & Environmental Engineering
- Weifang University
- Weifang
- P. R. China
| | - Yi Han
- Institute of Molecular Plus
- Tianjin University
- Tianjin
- P. R. China
| | - Wei Yuan
- Institute of Molecular Plus
- Tianjin University
- Tianjin
- P. R. China
| | - Changxiang Guo
- Institute of Molecular Plus
- Tianjin University
- Tianjin
- P. R. China
| | - Shiling Shi
- Institute of Molecular Plus
- Tianjin University
- Tianjin
- P. R. China
| | - Xia Liu
- Institute of Molecular Plus
- Tianjin University
- Tianjin
- P. R. China
| | - Yulan Chen
- Institute of Molecular Plus
- Tianjin University
- Tianjin
- P. R. China
| |
Collapse
|